Portage Biotech Inc.
PRTG
$5.42
-$0.54-9.06%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 1.67M | 1.67M | 1.76M | 3.33M | 5.03M |
Total Receivables | 12.00K | 12.00K | 570.00K | 23.00K | 39.00K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 475.00K | 475.00K | 275.00K | 1.78M | 2.56M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 68.00K | 68.00K | 77.00K | 63.00K | 64.00K |
Total Current Assets | 2.23M | 2.23M | 2.69M | 5.20M | 7.70M |
|
|||||
Total Current Assets | 2.23M | 2.23M | 2.69M | 5.20M | 7.70M |
Net Property, Plant & Equipment | -- | -- | 20.00K | 27.00K | 35.00K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -- | -- | -- | 14.00K | 49.00K |
Total Assets | 2.23M | 2.23M | 2.71M | 5.24M | 7.78M |
|
|||||
Total Accounts Payable | 427.00K | 427.00K | 221.00K | 1.56M | 482.00K |
Total Accrued Expenses | 660.00K | 660.00K | 588.00K | 1.31M | 2.31M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | 28.00K | 37.00K | 40.00K |
Total Finance Division Other Current Liabilities | 13.00K | 13.00K | 36.00K | 98.00K | 46.00K |
Total Other Current Liabilities | 13.00K | 13.00K | 36.00K | 98.00K | 46.00K |
Total Current Liabilities | 1.10M | 1.10M | 873.00K | 3.01M | 2.88M |
|
|||||
Total Current Liabilities | 1.10M | 1.10M | 873.00K | 3.01M | 2.88M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | 7.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 1.95M | 1.95M | 1.14M | 422.00K | 1.56M |
Total Liabilities | 3.05M | 3.05M | 2.01M | 3.43M | 4.45M |
|
|||||
Common Stock & APIC | 221.80M | 221.80M | 219.61M | 219.50M | 219.50M |
Retained Earnings | -245.45M | -245.45M | -242.33M | -240.97M | -239.32M |
Treasury Stock & Other | 23.53M | 23.53M | 24.13M | 23.99M | 23.84M |
Total Common Equity | -123.00K | -123.00K | 1.40M | 2.51M | 4.02M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -123.00K | -123.00K | 1.40M | 2.51M | 4.02M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -704.00K | -704.00K | -703.00K | -701.00K | -693.00K |
Total Equity | -827.00K | -827.00K | 695.00K | 1.81M | 3.33M |
|